These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 31132016)
1. Remarkable international variability in reasons for ineligibility and non-participation in the GLORIA trial. Hartman L; Bos R; Buttgereit F; Güler-Yuksel M; Ionescu R; Kok MR; Lems WF; Micaelo M; Opris-Belinski D; Pusztai A; Santos E; Da Silva J; Szekanecz Z; Zeiner K; Zhang D; Boers M Scand J Rheumatol; 2019 Jul; 48(4):340-341. PubMed ID: 31132016 [No Abstract] [Full Text] [Related]
2. Generalizability of Patients With Rheumatoid Arthritis in Biologic Agent Clinical Trials. Vashisht P; Sayles H; Cannella AC; Mikuls TR; Michaud K Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1478-88. PubMed ID: 26866293 [TBL] [Abstract][Full Text] [Related]
3. Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial. Hartman L; Rasch LA; Klausch T; Bijlsma HWJ; Christensen R; Smulders YM; Ralston SH; Buttgereit F; Cutolo M; Da Silva JAP; Opris D; Rovenský J; Szamosi S; Middelink LM; Lems WF; Boers M Trials; 2018 Jan; 19(1):67. PubMed ID: 29370811 [TBL] [Abstract][Full Text] [Related]
4. Reasons for ineligibility for a randomized clinical trial. Jean S; Richter KP; Ahluwalia JS; Schmelzle KH; Mayo MS J Health Care Poor Underserved; 2003 Aug; 14(3):324-30. PubMed ID: 12955913 [No Abstract] [Full Text] [Related]
5. Clinical Characteristics and Prognosis of Patients With Advanced Non-Small-cell Lung Cancer Who Are Ineligible for Clinical Trials. Kawachi H; Fujimoto D; Morimoto T; Ito M; Teraoka S; Sato Y; Nagata K; Nakagawa A; Otsuka K; Tomii K Clin Lung Cancer; 2018 Sep; 19(5):e721-e734. PubMed ID: 29934133 [TBL] [Abstract][Full Text] [Related]
6. Leveraging electronic health record data for pragmatic randomized trials. Roe MT Clin Trials; 2020 Aug; 17(4):368-369. PubMed ID: 32668979 [No Abstract] [Full Text] [Related]
7. Pragmatic randomized clinical trials: a proposal to enhance evaluation of new cancer therapies with early signs of exceptional activity. Koehler M; Donnelly ET; Kalanovic D; Dagher R; Rothenberg ML Ann Oncol; 2016 Jul; 27(7):1342-8. PubMed ID: 27029709 [No Abstract] [Full Text] [Related]
8. Validity versus generalizability in clinical trial design and conduct. Hennekens CH; Buring JE J Card Fail; 1998 Sep; 4(3):239-41. PubMed ID: 9754597 [No Abstract] [Full Text] [Related]
9. Patient Eligibility for Randomized Controlled Trials in Critical Care Medicine: An International Two-Center Observational Study. Ivie RM; Vail EA; Wunsch H; Goldklang MP; Fowler R; Moitra VK Crit Care Med; 2017 Feb; 45(2):216-224. PubMed ID: 27779514 [TBL] [Abstract][Full Text] [Related]
10. Clinical trials in rheumatology. Williams HJ Curr Opin Rheumatol; 1993 Mar; 5(2):146-52. PubMed ID: 8452764 [TBL] [Abstract][Full Text] [Related]
12. Generalizability of clinical trial results for bipolar disorder to community samples: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Hoertel N; Le Strat Y; Lavaud P; Dubertret C; Limosin F J Clin Psychiatry; 2013 Mar; 74(3):265-70. PubMed ID: 23561233 [TBL] [Abstract][Full Text] [Related]
13. Rheumatoid arthritis patients fulfilling Korean National Health Insurance reimbursement guidelines for anti-tumor necrosis factor-α treatment and comparison to other guidelines. Hur JW; Choe JY; Kim DW; Kim HA; Kim SH; Kim WU; Kim YS; Lee HS; Lee SH; Park SH; Park W; Park YB; Suh CH; Shim SC; Song YW; Yoon BY; Yu DY; Yoo DH Rheumatol Int; 2015 Nov; 35(11):1817-23. PubMed ID: 26342296 [TBL] [Abstract][Full Text] [Related]
14. Assessment of Pragmatism in Recently Published Randomized Clinical Trials. Janiaud P; Dal-Ré R; Ioannidis JPA JAMA Intern Med; 2018 Sep; 178(9):1278-1280. PubMed ID: 30039169 [TBL] [Abstract][Full Text] [Related]
15. Eligibility of real-life patients with COPD for inclusion in RCTs: a commentary. Battaglia S; Scichilone N Respir Res; 2017 Jan; 18(1):5. PubMed ID: 28057007 [TBL] [Abstract][Full Text] [Related]
16. The effect of glucocorticoids on bone mineral density in patients with rheumatoid arthritis: A systematic review and meta-analysis of randomized, controlled trials. Blavnsfeldt AG; de Thurah A; Thomsen MD; Tarp S; Langdahl B; Hauge EM Bone; 2018 Sep; 114():172-180. PubMed ID: 29913256 [TBL] [Abstract][Full Text] [Related]
17. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains. Lipman PD; Loudon K; Dluzak L; Moloney R; Messner D; Stoney CM Trials; 2017 Nov; 18(1):532. PubMed ID: 29126437 [TBL] [Abstract][Full Text] [Related]
18. Generalization and extrapolation of treatment effects from clinical studies in rheumatoid arthritis. Nair SC; Kievit W; Janse RW; Bijlsma JW; Fransen J; Lafeber FP; Welsing PM Arthritis Care Res (Hoboken); 2014 Jul; 66(7):998-1007. PubMed ID: 24375965 [TBL] [Abstract][Full Text] [Related]
19. Validity of area-under-the-curve analysis to summarize effect in rheumatoid arthritis clinical trials. Pham B; Cranney A; Boers M; Verhoeven AC; Wells G; Tugwell P J Rheumatol; 1999 Mar; 26(3):712-6. PubMed ID: 10090188 [TBL] [Abstract][Full Text] [Related]